Overview
FabiFlu 400 mg contains Favipiravir, a broad-spectrum antiviral agent primarily used in the treatment of influenza and mild to moderate COVID-19. It works by inhibiting the RNA-dependent RNA polymerase enzyme, thereby stopping viral replication inside human cells. Favipiravir has shown effectiveness against RNA viruses under clinical guidance.





